KREMEN2 and gastric adenocarcinoma: Recent research reveals that Kremen2 is upregulated in various tumours, such as renal clear cell carcinoma, breast invasive carcinoma, COAD, and stomach adenocarcinoma, in comparison to that in normal tissues (8).